Private practice with Dr Seth Bilazarian
View all posts »DES or bare-metal stents in STEMI patients?
Apr 20, 2010 09:30 EDT-
1Comments
-
Read later
Randomized clinical trials do not seem to have contributed to a definite answer regarding the selection of drug-eluting or bare-metal stent for acute MI. What is your rationale when making your decision?
See:
DES in AMI: Benefits maintained at three years in SESAMI
Two-year Massachusetts registry results support mortality benefit of DES in AMI
DES in AMI: Some reassurances, more questions from TYPHOON and STRATEGY
HORIZONS AMI: Drug-eluting stent safe and effective in the setting of STEMI
Your comments
|
||||
|
|
|
|||
|
|
|
|||
You must be a member (with full membership) to post a comment.
Already a member?
Enjoy all the benefits of theheart.org
With full membership, you can check out our educational and editorial content, search the site, receive our newsletters, join discussions, download slides and much more.
Membership is free!












